Filter posts

Jim Greenwood guest appearance on CNBC’s “Squawk Box” during this morning’s “Health Care S...

BIO President and CEO Jim Greenwood joined former HHS Secretary Tommy Thompson and former FDA …

Clearing Another Hurdle on the Pathway to Biosimilars

The House Energy and Commerce Committee, by a vote of 47 to 11, overwhelmingly adopted …

Patient groups join call for data protection

Biomedical innovation is not only key to our industry’s future, but more importantly, continued medical …

Victory on Biosimilars in Senate HELP Committee - But Still a Long Way from the Finish Line

Last evening the Senate Health, Education, Labor and Pensions (HELP) Committee adopted an amendment to …

The Washington Post: Special section on biotechnology

As part of our public education/industry branding campaign, BIO sponsored a special section on biotechnology …

Health Reform Debate Heats Up and Slows Down

The health reform debate is heating up and, in at least one respect, slowing down …

Already Looking Ahead to BIO 2010 in Chicago

The whirlwind of the BIO 2009 International Convention has come to a close. For the …

Podcast: Jim Greenwood Gives State of the Industry Address at BIO 2009 in Atlanta

My fellow biotech industry workers… Jim Greenwood told the 12,000 to 15,000 attendees of the …

From Jim Greenwood: Things are humming in Atlanta

I arrived Thursday to begin the pre-conference media interviews and to speak at some events …

Jim Greenwood and Andrew Young on Fox Business: The Future of Biotechnology

Jim Greenwood and Andrew Young appear on Fox Business to discuss the future of biotechnology.